Your browser doesn't support javascript.
loading
Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA).
Wagner, Michael J; Mitra, Rahul; McArthur, Mark J; Baze, Wallace; Barnhart, Kirstin; Wu, Sherry Y; Rodriguez-Aguayo, Cristian; Zhang, Xinna; Coleman, Robert L; Lopez-Berestein, Gabriel; Sood, Anil K.
Afiliação
  • Wagner MJ; Division of Cancer Medicine, MD Anderson Cancer Center, Houston, Texas.
  • Mitra R; Department of Gynecologic Oncology, MD Anderson Cancer Center, Houston, Texas.
  • McArthur MJ; Department of Gynecologic Oncology, MD Anderson Cancer Center, Houston, Texas.
  • Baze W; Center for RNA Interference and Non-Coding RNA, MD Anderson Cancer Center, Houston, Texas.
  • Barnhart K; Department of Veterinary Medicine and Surgery, MD Anderson Cancer Center, Houston, Texas.
  • Wu SY; Department of Veterinary Medicine and Surgery, MD Anderson Cancer Center, Houston, Texas.
  • Rodriguez-Aguayo C; Department of Veterinary Medicine and Surgery, MD Anderson Cancer Center, Houston, Texas.
  • Zhang X; Department of Gynecologic Oncology, MD Anderson Cancer Center, Houston, Texas.
  • Coleman RL; Center for RNA Interference and Non-Coding RNA, MD Anderson Cancer Center, Houston, Texas.
  • Lopez-Berestein G; Center for RNA Interference and Non-Coding RNA, MD Anderson Cancer Center, Houston, Texas.
  • Sood AK; Center for RNA Interference and Non-Coding RNA, MD Anderson Cancer Center, Houston, Texas.
Mol Cancer Ther ; 16(6): 1114-1123, 2017 06.
Article em En | MEDLINE | ID: mdl-28265009
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fosfatidilcolinas / Receptor EphA2 / RNA Interferente Pequeno / Interferência de RNA / Nanopartículas / Lipossomos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2017 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fosfatidilcolinas / Receptor EphA2 / RNA Interferente Pequeno / Interferência de RNA / Nanopartículas / Lipossomos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2017 Tipo de documento: Article País de publicação: Estados Unidos